Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients
Role of Artificial Intelligence in the Prediction of AKI in Critically Ill Patients
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
The assessment of AI -based prediction models in detecting AKI early in critically ill patients. Specifically, the aim is to evaluate the model's ability to predict the onset of AKI before it clinically manifests allowing for early interventions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2025
CompletedFirst Posted
Study publicly available on registry
March 4, 2025
CompletedStudy Start
First participant enrolled
May 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMay 16, 2025
May 1, 2025
10 months
February 26, 2025
May 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The assessment of AI -based prediction models in detecting AKI early in critically ill patients.
assessment of the ability of the AI based model to detect AKI in critically ill patients by evaluating the model ability to predict the onset of early AKI before it is clinically manifested for early interventions . this will be done by generating an AKI risk score by the model for each patient. Outcomes are tracked and the model is updated periodically based on new patient data to improve accuracy and reliability
1 year
Secondary Outcomes (1)
assessment of other aspects
1 year
Eligibility Criteria
Baseline characteristics, including demographic information, comorbidities, vital signs, laboratory results, medical interventions, disease severity scores, etc. were carefully reviewed and collected. The definitions of comorbidities including congestive heart failure, peptic ulcer disease, myocardial infarction, peripheral vascular disease, diabetes, dementia, chronic pulmonary disease, rheumatic disease, cerebrovascular disease, cancer, paraplegia, liver disease, renal disease, and acquired immunedeficiency syndrome. Severe organ failure due to ineffective immune response to infection was identified as sepsis. During the first 24 h when the patient was admitted to the ICU, the average values of the patient's vital signs (heart rate, mean arterial pressure, respiration rate, body temperature, and SpO2) were measured,, and the highest value of the biochemical laboratory tests (hematocrit, hemoglobin, platelets, white blood cell, blood urea nitrogen, international normalized ratio, Scr,
You may qualify if:
- All adult (aged 18 years old and older) patients who were admitted to the ICU were included in this study.
You may not qualify if:
- patients under 18 years old
- End-stage renal disease
- Acute Kidney Injury at ICU admission
- Inability to obtain sufficient clinical data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Alaa El-Dein ElMoneim Sayed, professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisstant lecturer of critical care
Study Record Dates
First Submitted
February 26, 2025
First Posted
March 4, 2025
Study Start
May 14, 2025
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
May 16, 2025
Record last verified: 2025-05